BOI company saves Rs.1.5bn through manufacture of saline locally

Kelun Lifesciences (Pvt.) Ltd, one of the largest pharmaceutical manufacturing facilities in Sri Lanka, located at the Kandy Industrial Park, fulfils 40 percent of total demand for saline in the country and has saved over Rs.1.5 billion through the manufacture of saline locally since 2017.
This was revealed during an official visit to the Industrial Park by Investment Promotion State Minister Dilum Amunugama, Board of Investment (BOI) Director General Renuka M. Weerakone and Executive Director (Zones) M.K.D. Lawrance.

Kelun Lifesciences, an Indian investment, commenced operation in 2017. A total of 230 employees are currently employing at the factory. 
During the visit, Amunugama chaired a meeting with the participation of the investors of the Industrial Park, to discuss and iron out the issues faced by them.
Addressing the investors, Amunugama stated, “It is evident and undeniable that local productions and exports have been largely hit by global and local recessions, resulting in low production and exports.

In this context, the government is keen on taking pertinent measures to ensure the smooth operation of the local industries in the face of the global and local economic setbacks,” he underscored.
Amunugama proceeded to say that the Investment Promotion Ministry is in the process of making short and long-term strategies to address the contemporary issues confronted by the industry players, so that they could carry on the operations without a hitch. 
The Kandy Industrial Park, a 114-acre land, houses 24 factories, with over 10,400 worker population.